82 related articles for article (PubMed ID: 22487958)
21. Formation, physical stability and in vitro antimalarial activity of dihydroartemisinin nanosuspensions obtained by co-grinding method.
Chingunpitak J; Puttipipatkhachorn S; Chavalitshewinkoon-Petmitr P; Tozuka Y; Moribe K; Yamamoto K
Drug Dev Ind Pharm; 2008 Mar; 34(3):314-22. PubMed ID: 18363147
[TBL] [Abstract][Full Text] [Related]
22. In vivo assessment of oral administration of probucol nanoparticles in rats.
Shudo J; Pongpeerapat A; Wanawongthai C; Moribe K; Yamamoto K
Biol Pharm Bull; 2008 Feb; 31(2):321-5. PubMed ID: 18239296
[TBL] [Abstract][Full Text] [Related]
23. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
Fini A; Cavallari C; Ospitali F
Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
[TBL] [Abstract][Full Text] [Related]
24. Development of novel polymer-stabilized diosmin nanosuspensions: in vitro appraisal and ex vivo permeation.
Freag MS; Elnaggar YS; Abdallah OY
Int J Pharm; 2013 Sep; 454(1):462-71. PubMed ID: 23830765
[TBL] [Abstract][Full Text] [Related]
25. Stable carbamazepine colloidal systems using the cosolvent technique.
Douroumis D; Fahr A
Eur J Pharm Sci; 2007 Apr; 30(5):367-74. PubMed ID: 17234395
[TBL] [Abstract][Full Text] [Related]
26. Nanoparticle formation from probucol/PVP/sodium alkyl sulfate co-ground mixture.
Wanawongthai C; Pongpeerapat A; Higashi K; Tozuka Y; Moribe K; Yamamoto K
Int J Pharm; 2009 Jul; 376(1-2):169-75. PubMed ID: 19409462
[TBL] [Abstract][Full Text] [Related]
27. Assessment of formulation robustness for nano-crystalline suspensions using failure mode analysis or derisking approach.
Nakach M; Authelin JR; Voignier C; Tadros T; Galet L; Chamayou A
Int J Pharm; 2016 Jun; 506(1-2):320-31. PubMed ID: 27102992
[TBL] [Abstract][Full Text] [Related]
28. Application of the combinative particle size reduction technology H 42 to produce fast dissolving glibenclamide tablets.
Salazar J; Müller RH; Möschwitzer JP
Eur J Pharm Sci; 2013 Jul; 49(4):565-77. PubMed ID: 23587645
[TBL] [Abstract][Full Text] [Related]
29. Nanoscale surface characterization and miscibility study of a spray-dried injectable polymeric matrix consisting of poly(lactic-co-glycolic acid) and polyvinylpyrrolidone.
Meeus J; Chen X; Scurr DJ; Ciarnelli V; Amssoms K; Roberts CJ; Davies MC; van Den Mooter G
J Pharm Sci; 2012 Sep; 101(9):3473-85. PubMed ID: 22447580
[TBL] [Abstract][Full Text] [Related]
30. Morphology and surface States of colloidal probucol nanoparticles evaluated by atomic force microscopy.
Moribe K; Wanawongthai C; Shudo J; Higashi K; Yamamoto K
Chem Pharm Bull (Tokyo); 2008 Jun; 56(6):878-80. PubMed ID: 18520102
[TBL] [Abstract][Full Text] [Related]
31. Lipid nanoparticles for brain targeting III. Long-term stability and in vivo toxicity.
Blasi P; Schoubben A; Traina G; Manfroni G; Barberini L; Alberti PF; Cirotto C; Ricci M
Int J Pharm; 2013 Sep; 454(1):316-23. PubMed ID: 23832009
[TBL] [Abstract][Full Text] [Related]
32. Effect of temperature and moisture on the miscibility of amorphous dispersions of felodipine and poly(vinyl pyrrolidone).
Marsac PJ; Rumondor AC; Nivens DE; Kestur US; Stanciu L; Taylor LS
J Pharm Sci; 2010 Jan; 99(1):169-85. PubMed ID: 19492305
[TBL] [Abstract][Full Text] [Related]
33. Development and characterization of lecithin stabilized glibenclamide nanocrystals for enhanced solubility and drug delivery.
Kumar BS; Saraswathi R; Kumar KV; Jha SK; Venkates DP; Dhanaraj SA
Drug Deliv; 2014 May; 21(3):173-84. PubMed ID: 24102185
[TBL] [Abstract][Full Text] [Related]
34. Single-step preparation and deagglomeration of itraconazole microflakes by supercritical antisolvent method for dissolution enhancement.
Sathigari SK; Ober CA; Sanganwar GP; Gupta RB; Babu RJ
J Pharm Sci; 2011 Jul; 100(7):2952-65. PubMed ID: 21344415
[TBL] [Abstract][Full Text] [Related]
35. Non-destructive methods of characterization of risperidone solid lipid nanoparticles.
Rahman Z; Zidan AS; Khan MA
Eur J Pharm Biopharm; 2010 Sep; 76(1):127-37. PubMed ID: 20470882
[TBL] [Abstract][Full Text] [Related]
36. Effect of wet milling process on the solid state of indomethacin and simvastatin.
Sharma P; Denny WA; Garg S
Int J Pharm; 2009 Oct; 380(1-2):40-8. PubMed ID: 19576976
[TBL] [Abstract][Full Text] [Related]
37. Preliminary evaluation of polymer-based drug composite microparticle production by coacervate desolvation with supercritical carbon dioxide.
Yasuji T; Haslam J; Kajiyama A; McIntosh MP; Rajewski RA
J Pharm Sci; 2006 Mar; 95(3):581-8. PubMed ID: 16419052
[TBL] [Abstract][Full Text] [Related]
38. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
Dhumal RS; Shimpi SL; Paradkar AR
Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
[TBL] [Abstract][Full Text] [Related]
39. Comparison of different methods for preparation of a stable riccardin D formulation via nano-technology.
Liu G; Zhang D; Jiao Y; Zheng D; Liu Y; Duan C; Jia L; Zhang Q; Lou H
Int J Pharm; 2012 Jan; 422(1-2):516-22. PubMed ID: 22119965
[TBL] [Abstract][Full Text] [Related]
40. Understanding a relaxation behavior in a nanoparticle suspension for drug delivery applications.
Deng Z; Xu S; Li S
Int J Pharm; 2008 Mar; 351(1-2):236-43. PubMed ID: 18093763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
